A rating of 71 puts PainReform Ltd (PRFX) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. PainReform Ltd's score of 71 means it scores higher than 71% of stocks in the industry. PainReform Ltd also received an overall rating of 49, putting it above 49% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 108 out of the 148 industries.
PRFX has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on PRFX!
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With PainReform Ltd Stock Today?
PainReform Ltd (PRFX) stock is trading at $4.37 as of 10:13 AM on Monday, Sep 11, an increase of $0.09, or 2% from the previous closing price of $4.28. The stock has traded between $4.23 and $4.43 so far today. Volume today is below average. So far 8,566 shares have traded compared to average volume of 110,851 shares.
Click Here to get the full Stock Report for PainReform Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
